GLP-1 Drugs Could Soon Be Taken Just Once Every Three Months
Researchers are working on new formulations of GLP-1 drugs that could reduce how often patients need to take them — potentially shifting from weekly injections to just once a quarter.
CONTINUE READING ▸
Some GLP-1 Users Feel Fat Even After Losing Weight — Here’s Why
A psychological phenomenon called "ghost fat" is being reported among people who've lost significant weight on GLP-1 drugs — they continue to see themselves as overweight even after the pounds are gone, similar to body dysmorphia.
CONTINUE READING ▸
Breast Cancer Patients on GLP-1 Drugs Had Higher Survival Rates
A large observational study found that breast cancer patients who took GLP-1 drugs had better survival outcomes compared to those who didn't. Researchers say the findings are promising but call for formal clinical trials to confirm whether the drugs are actually responsible for the benefit.
CONTINUE READING ▸
Why GLP-1 Drugs Can Be Risky for People with Disordered Eating
A therapist who specializes in eating disorders addresses the complicated pull that GLP-1 weight-loss drugs can have for people already struggling with their relationship with food.
CONTINUE READING ▸
A DNA Test Claims to Predict Whether GLP-1 Drugs Will Work for You
A new at-home genetic test called MyPhenome claims it can tell you whether your body is likely to respond to GLP-1 weight-loss drugs before you spend thousands of dollars on them.
CONTINUE READING ▸
GLP-1 Users Are Walking Less and Exercising Less, Study Finds
A new study found that people taking GLP-1 weight-loss drugs became less physically active over time — daily steps dropped from about 5,047 to 4,487, and moderate exercise fell from 28 to 22 minutes per day.
CONTINUE READING ▸
Employers Are Rethinking Whether to Keep Covering GLP-1 Weight-Loss Drugs
As GLP-1 drugs like Wegovy become more popular, employers are under growing financial pressure and some are reconsidering whether to cover them for weight loss at all.
CONTINUE READING ▸
Experts Weigh In on Whether You Need GLP-1 Drugs Forever
If you're taking a GLP-1 drug like Ozempic or Wegovy, you might be wondering whether you'll need to stay on it indefinitely. Experts are increasingly discussing the long-term safety and necessity of these medications, since weight often returns when people stop taking them.
CONTINUE READING ▸Online GLP-1 Weight Loss Drug Sales Raise Safety Concerns
Many telehealth companies are making GLP-1 weight loss drugs easily available online as demand soars. This easy access is raising concerns about potential overdoses and safety issues when these powerful medications aren't properly supervised by healthcare providers.
CONTINUE READING ▸
Medicare Will Cover GLP-1 Weight Loss Drugs Starting in 2026
Medicare beneficiaries will be able to get coverage for GLP-1 medications for weight loss starting in 2026. Currently, Medicare covers these drugs for specific conditions like type 2 diabetes, but the expanded coverage will include weight management.
CONTINUE READING ▸
Weight Loss Drugs May Reshape Brain and Nervous System
New research suggests GLP-1 weight loss drugs might be changing how the brain and nervous system function. Scientists are investigating whether these medications could have broader effects on brain structure and neural networks beyond their intended weight loss benefits.
CONTINUE READING ▸
New Oura Ring 5 Adds Blood Pressure and GLP-1 Tracking
The latest Oura Ring includes blood pressure monitoring and tools to track GLP-1 medications alongside existing health features. The smart ring is expanding beyond sleep and fitness to offer comprehensive health monitoring including medical record integration.
CONTINUE READING ▸
Oura Ring Adds GLP-1 Drug Tracking Features
Oura Ring is introducing new features that let users track their GLP-1 doses, log symptoms, and monitor long-term health trends. The wearable device is expanding beyond fitness tracking to help people manage their weight loss medication journey.
CONTINUE READING ▸
CVS Expands Insurance Coverage Options for GLP-1 Weight Loss Drugs
CVS Caremark is expanding coverage options for GLP-1 weight management medications to make them more affordable and accessible. The expanded coverage aims to create sustainable access to these important medications for more members.
CONTINUE READING ▸
Doctors Concerned About GLP-1 Use Among Eating Disorder Patients
Healthcare providers are alarmed to find patients with anorexia, bulimia, and binge eating disorders are taking GLP-1 weight loss drugs. This trend is raising serious concerns about the safety of these medications for people with existing eating disorders.
CONTINUE READING ▸
New Daily Oral GLP-1 Drug Approved for Weight Loss and Diabetes
The FDA approved orforglipron, a once-daily pill that works like Ozempic and Wegovy but doesn't require injections. The oral medication helps people lose 5-10% of their body weight and lowers blood sugar levels without fasting requirements.
CONTINUE READING ▸
Major Changes Coming to GLP-1 Drug Market and Coverage
The GLP-1 medication market is seeing significant changes, including FDA approval of oral weight loss drugs and expanded Medicare coverage starting in July 2024. These shifts could make weight loss medications more accessible to patients.
CONTINUE READING ▸
Compounding Pharmacies Challenge Big Pharma GLP-1 Drug Sales
The growing peptide market is creating competition for brand-name GLP-1 drugs as compounding pharmacies offer alternatives to expensive medications. This trend is causing tension between commercial drug companies and compounding pharmacies over patient access to weight loss treatments.
CONTINUE READING ▸
Regular Foods Can’t Match GLP-1 Drugs for Appetite Control
Natural GLP-1 hormone levels from eating regular foods have little effect on appetite or weight loss, according to researchers. The much higher hormone levels achieved through medications like Ozempic are what actually reduce hunger and help with weight loss.
CONTINUE READING ▸
GLP-1 Weight Loss Drugs May Affect Mental Health and Mood
Some patients taking GLP-1 medications for weight loss report experiencing less pleasure and excitement in their daily lives. This potential mental health side effect is raising concerns among doctors and patients about the emotional impact of these popular weight loss drugs.
CONTINUE READING ▸